Qure.ai
Founded Year
2016Stage
Series D | AliveTotal Raised
$125.99MLast Raised
$65M | 3 mos agoRevenue
$0000Mosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-26 points in the past 30 days
About Qure.ai
Qure.ai specializes in leveraging artificial intelligence to enhance healthcare accessibility and affordability, focusing on the healthcare sector. The company provides AI-powered tools for medical image analysis, including chest x-ray interpretation and management of various conditions such as lung nodules, strokes, and heart failure. Its solutions are designed to assist healthcare professionals in diagnosing and treating diseases, with a significant presence in the global healthcare AI market. It was founded in 2016 and is based in Mumbai, India.
Loading...
Qure.ai's Product Videos
_thumbnail.png?w=3840)
ESPs containing Qure.ai
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The radiology AI — stroke detection market is focused on using AI to analyze ultrasound images and CT scans to detect signs of stroke and triage large vessel occlusions (LVO). Vendors in this market offer solutions that can identify pathology and notify care teams, provide high-fidelity imaging and patient information, and coordinate care to ensure patients are directed to the right provider. Thes…
Qure.ai named as Highflier among 12 other companies, including Aidoc, Viz.ai, and Clarius Mobile Health.
Qure.ai's Products & Differentiators
qXR
can detect abnormal findings on a chest X-ray. Its is a CE-certified patented algorithms that can detect a total of 30 findings on the chest X-ray.
Loading...
Research containing Qure.ai
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Qure.ai in 4 CB Insights research briefs, most recently on Apr 3, 2024.
Expert Collections containing Qure.ai
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Qure.ai is included in 4 Expert Collections, including Artificial Intelligence.
Artificial Intelligence
14,767 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Digital Health 50
300 items
The winners of the second annual CB Insights Digital Health 150.
Digital Health
11,072 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Oncology Tech
457 items
This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.
Qure.ai Patents
Qure.ai has filed 16 patents.
The 3 most popular patent topics include:
- artificial neural networks
- machine learning
- medical imaging
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/12/2023 | 4/23/2024 | Grant |
Application Date | 10/12/2023 |
|---|---|
Grant Date | 4/23/2024 |
Title | |
Related Topics | |
Status | Grant |
Latest Qure.ai News
Sep 23, 2024
Saritha Rai / Bloomberg: Mumbai-based Qure.AI, which uses AI to help identify and manage critical diseases at 3K+ imaging sites, raised a $65M Series D led by Lightspeed and 360 ONE — It plans to use the proceeds to expand in the US and other markets, improve its generative AI foundation models and fund acquisitions.
Qure.ai Frequently Asked Questions (FAQ)
When was Qure.ai founded?
Qure.ai was founded in 2016.
Where is Qure.ai's headquarters?
Qure.ai's headquarters is located at Level 6, Oberoi Commerz II, Goregaon East, Mumbai.
What is Qure.ai's latest funding round?
Qure.ai's latest funding round is Series D.
How much did Qure.ai raise?
Qure.ai raised a total of $125.99M.
Who are the investors of Qure.ai?
Investors of Qure.ai include Novo Holdings, Healthquad, Kae Capital, 360 ONE, Lightspeed Venture Partners and 14 more.
Who are Qure.ai's competitors?
Competitors of Qure.ai include Subtle Medical, Quibim, Deep Breath Intelligence, Aidoc, Rology and 7 more.
What products does Qure.ai offer?
Qure.ai's products include qXR and 3 more.
Who are Qure.ai's customers?
Customers of Qure.ai include NHS Trusts and vRAD.
Loading...
Compare Qure.ai to Competitors
RADLogics is a healthcare software company that focuses on developing artificial intelligence (AI)-powered solutions in the medical imaging industry. The company's main offerings include machine learning image analysis solutions that aim to improve radiologists' productivity and enhance patient outcomes by reducing diagnostic turnaround time and automating detection and report generation functions. RADLogics primarily serves the healthcare industry. It was founded in 2010 and is based in New York, New York.
Kheiron Medical Technologies specializes in AI-powered solutions for radiology, with a focus on early cancer detection in the healthcare sector. The company offers a suite of tools that assist radiologists in interpreting mammograms and making informed decisions about breast cancer screening. Kheiron's products are designed to improve accuracy and efficiency in cancer diagnostics, backed by clinical trial validations. Kheiron Medical Technologies was formerly known as Maesterai. It was founded in 2016 and is based in London, England.
Arterys is a company that focuses on the integration of artificial intelligence and data in the medical sector, specifically in the domain of radiology. The company offers a cloud-based platform that uses AI to extract actionable insights from medical images, aiming to improve diagnostic decision making, efficiency, and productivity. Its services primarily cater to the healthcare industry. Arterys was formerly known as Morpheus Medical, Inc.. It was founded in 2011 and is based in San Francisco, California.
AIRS Medical serves as a healthcare AI company specializing in MRI imaging through technology. Its main offerings include AI solutions that improve the quality and efficiency of MRI scans by reducing scan times and utilizing deep learning for image reconstruction. AIRS Medical primarily serves the healthcare sector, with a focus on radiology and diagnostic imaging centers. It was founded in 2018 and is based in Seoul, South Korea.
Incepto Medical is a company focused on the intersection of artificial intelligence and medical imaging within the healthcare industry. The company offers a unified platform that integrates AI applications for radiology, assisting in diagnostics, image quantification, characterization, and reconstruction. These AI solutions are primarily used in the medical imaging sector, aiding healthcare professionals in managing the volume of patients and images. It was founded in 2018 and is based in Paris, France.
Koios Medical specializes in AI-based clinical decision support software for healthcare. The company offers FDA-cleared and CE Marked Smart Ultrasound software that utilizes artificial intelligence and machine learning to assist radiologists in the diagnosis of breast and thyroid cancers. Its products are designed to integrate the radiology suite. Koios Medical was formerly known as Clearview Diagnostics. It was founded in 2012 and is based in Chicago, Illinois.
Loading...